CANGENE
Cangene is a fully integrated developer and manufacturer of immune therapeutics. Our first drug, WinRho® SDF, has been commercially available since 1980, and since then we have established a solid track record of developing and commercializing plasma-derived products that address multiple therapeutic areas. Our current product portfolio consists of purified, concentrated antibody preparations (hyperimmunes) with target applications in infectious disease, hematology, transplantation and biodefense. Four of our hyperimmune products are approved in the United States and/or Canada, and three products are included in the U.S. Strategic National Stockpile. We are committed to the safety and quality of our products, the service of our customers, and the interests of our shareholders.
CANGENE
Social Links:
Industry:
Biotechnology Manufacturing
Founded:
1984-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.cangene.com
Total Employee:
251+
Status:
Active
Contact:
2042754021
Email Addresses:
[email protected]
Technology used in webpage:
GoDaddy DNS Incapsula Cisco Ironport Cloud
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-07-07 | Twinstrand Therapeutics | Twinstrand Therapeutics acquired by Cangene | N/A |
Official Site Inspections
http://www.cangene.com
- Host name: edge.redirect.pizza
- IP address: 89.106.200.1
- Location: Luxembourg
- Latitude: 49.7498
- Longitude: 6.1661
- Timezone: Europe/Luxembourg
More informations about "Cangene"
Cangene Corporation, Winnipeg, Manitoba - CompanyListing.ca
Emergent BioSolutions to Acquire Cangene Corporation
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into a definitive agreement with Cangene Corporation (TSX: CNJ) under which Emergent will acquire all of the …See details»
Cangene - Crunchbase Company Profile & Funding
Cangene is a fully integrated developer and manufacturer of immune therapeutics. Our first drug, WinRho® SDF, has been commercially available since 1980, and since then we have …See details»
Cangene Announces Completion of Acquisition by Emergent
Feb 21, 2014 Cangene also operates a plasma-collection facility in Winnipeg, Manitoba under the name Cangene Plasma Resources. Its U.S. sales and marketing office is located in …See details»
Organization | Cangene - Purdue University
Glossary Advanced Search Guide Search by Name Cangene Report issue Contributed to NMEFor profitPhase 1Phase 3Phase 4 Founded:Winnipeg CanadaSee details»
Cangene Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, acquisitions, investors, and executives for Cangene. Use the PitchBook Platform to explore the full profile.See details»
Cangene Biopharma Careers and Employment - Indeed
Nov 8, 2017 Find out what works well at Cangene Biopharma from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»
Cangene - Contacts, Employees, Board Members, Advisors & Alumni
Cangene is a fully integrated developer and manufacturer of immune therapeutics. Our first drug, WinRho® SDF, has been commerciallySee details»
Cangene Corporation - Nondestructive Testing
104 Chancellor Matheson Rd Winnipeg MB Manitoba Canada R3T 5Y3WinnipegSee details»
Cangene Corporation | Insights
Latest on Cangene Corporation Already A Biomedtracker Subscriber?You have access to the full company record through your subscription.See details»
Cangene bioPharma facility renovation is complete and operating …
May 3, 2011 Cangene is focused on developing therapeutics for infectious diseases, and the Company uses patented manufacturing processes to produce plasma-derived and …See details»
Cangene bought by U.S. rival for $236-million, latest Canadian …
Dec 12, 2013 Cangene president John Sedor said his company will benefit from becoming part of Emergent, which is "a leader in developing vaccines, as well as therapeutics for addressing …See details»
CANGENE ANNOUNCES CORPORATE REORGANIZATION WITHIN …
TORONTO and WINNIPEG, Nov. 5 /CNW/ - Cangene Corporation today announces the merger of its indirect, wholly-owned subsidiaries, Mid-Florida Biologicals, Inc. and Biotherapeutic …See details»
Cangene acquires U.S. commercialization rights for HepaGam B
Oct 19, 2009 Cangene is focused on developing therapeutics for infectious diseases, and the Company uses patented manufacturing processes to produce plasma-derived and …See details»
Cangene Corp. (Cangene Corp.) - 药物管线_专利_临床试验_投融营 …
了解Cangene Corp. (Cangene Corp.)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 7篇新闻和90篇文献，疾病领域:感染，血液及淋巴系统疾病，免疫系统疾病，神经系统疾 …See details»
Cargene - Crunchbase Company Profile & Funding
Dec 14, 2021 Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases.See details»
CanGene-CanVar | Research - Cancer Susceptibility Genetics
CanGene-CanVar is a five-year CRUK-funded research program developing data resources, clinical and educational tools to leverage cancer susceptibility genetics for early detection and …See details»
CanGenX™
Founded in 2014, with the goal of using advanced technologies to develop products and services needed for all level of growers in the legal cannabis industry, CanGenX™ has been focused …See details»
CannGen Insurance | Cannabis Insurance Program
CannGen underwrites a comprehensive package of coverages with A-Rated carriers to protect the cannabis industry. Get covered today.See details»